Evidence map›Paper›PMID 41388220›Full record

SynthesisInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026

Previable PROM in twins: A systematic review and meta-analysis.

Marwan Odeh, Maya Frank Wolf, Forsan Kenaan, Raneen Sawaid Kaiyal, Ala Aiob, Lior Lowenstein, Inshirah Sgayer

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marwan OdehRaya Strauss Wing of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.
Maya Frank WolfRaya Strauss Wing of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.
Forsan KenaanPediatrics Department, Galilee Medical Center, Nahariya, Israel.
Raneen Sawaid KaiyalRaya Strauss Wing of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.
Ala AiobRaya Strauss Wing of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.
Lior LowensteinRaya Strauss Wing of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.
Inshirah SgayerRaya Strauss Wing of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.ORCID https://orcid.org/0000-0002-5270-8436

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPreviable prelabor rupture of membranes (PROM) in twin pregnancies is a rare but high-risk condition associated with substantial neonatal mortality and maternal morbidity. Management options include expectant management and selective reduction, though guidance is limited and based primarily on singleton data. Emerging reports suggest selective reduction may improve outcomes for the unaffected co-twin by prolonging latency and reducing maternal complications.

objectivesTo evaluate maternal, obstetric, and neonatal outcomes in twin pregnancies complicated by previable PROM before 24 weeks of gestation, and to compare outcomes following expectant management and selective reduction. SEARCH STRATEGY: A comprehensive literature search was conducted in Medline, Embase, and Web of Science for studies published between January 1990 and September 2024. SELECTION CRITERIA: Eligible studies included case reports, case series, and cohort studies, reporting outcomes of twin pregnancies with previable prelabor rupture of membranes (PPROM) managed either expectantly or by selective reduction of the affected twin. DATA COLLECTION AND ANALYSIS: Data on maternal, obstetric, and neonatal outcomes were extracted and pooled for analysis. Subgroup analyses were performed based on management strategy: selective reduction versus expectant management. MAIN

resultsA total of 45 studies were included, comprising 286 twin pregnancies with previable PROM. Selective reduction was performed in 16.4% (n = 47) of the pregnancies. Across the entire cohort, no infant was discharged home alive in 32.0% of the pregnancies, one infant in 51.6%, and two infants in only 16.4%. Clinical chorioamnionitis occurred in 33.5%, maternal sepsis in 7.8%, septic shock in 1.6%, and hysterectomy in 0.8%. Compared to expectant management, selective reduction was associated with longer latency (15.0 ± 8.4 vs. 8.3 ± 5.7 weeks), higher gestational age at delivery (31.6 ± 7.7 vs. 24.4 ± 4.4 weeks), and higher birth weight (2663.6 ± 703.9 vs. 1251.3 ± 773.0 g) of the co-twin, all P < 0.001. Following selective reduction compared to expectant management, the discharge home of one live infant was more common (66.0% vs. 33.8%, P < 0.001), yet the discharge of two infants was not possible (0.0% vs. 25.7%, P < 0.001). Following selective reduction, clinical chorioamnionitis and neonatal death were lower (19.1% vs. 40.3%, P = 0.008 and 3.6% vs. 17.1%, P = 0.033, respectively).

conclusionsTwin pregnancies with PPROM are associated with high maternal and neonatal risks. Selective reduction may improve outcomes for the unaffected twin and reduce maternal morbidity. These findings underscore the need for individualized, multidisciplinary counseling and highlight the critical gaps in evidence guiding management in this rare clinical scenario.

Indexed as

Pregnancy Reduction, MultifetalPregnancy, TwinPremature Rupture of Fetal MembranesFemaleGestational AgeHumansInfant, NewbornPregnancyPregnancy OutcomeWatchful Waitingexpectant managementneonatal outcomespreviable prelabor rupture of membranesselective reductiontwin pregnancy

Identifiers

PMID41388220
PMCPMC13173602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.